Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954746 · ClinicalTrials.gov registry record
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
A clinical trial, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- 645
- Enrollment target
NCT00954746: Completed study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT00954746 is a clinical trial that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 645 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00954746 has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- 645 participants
- Enrollment target
Study Summary
The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 645 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-05 |
What the finished NCT00954746 record still lists
NCT00954746 is an observational study that tracks outcomes without assigning an intervention. The registered 645 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00954746 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00954746 about?
NCT00954746 is a clinical study titled "Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859". The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
What is the current status of trial NCT00954746?
This trial is currently completed. The enrollment target is 645 participants. The study started on 2009-07. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00954746?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07012395 · 645 participants · Phase 2
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- NCT04863222 · 646 participants · Phase 4
Clinical and Radiographic Success of MTA vs Biodentine
- NCT05146297 · 644 participants · NA
Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials
- NCT06994442 · 644 participants · Phase 3
Optimizing Pain Treatment in Children On Mechanical Ventilation
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia